Group 1 - The company, Shibai Testing (301228), reported that as of September 30, 2025, the total number of shareholders is 6,671 [1]

Core Insights - Neogen Corp. reported better-than-expected first-quarter sales results, leading to a stock rally [1][4] - Analysts from William Blair noted transient issues affecting performance but expect improvements in the future [2] - The company reaffirmed its fiscal 2026 sales guidance of $820 million to $840 million, slightly above consensus estimates [3] Financial Performance - First-quarter adjusted earnings were 4 cents per share, aligning with estimates, while sales reached $209.19 million, down 3.6% year-over-year but exceeding consensus of $204.16 million [5] - Gross margin for Q1 was 45.4%, down from 48.4% a year ago, attributed to production relocation and lower revenue [5] - Adjusted EBITDA for the first quarter was $35.5 million, with an adjusted EBITDA margin of 17.0%, compared to $43.7 million and a margin of 20.1% in the previous year [5] Segment Performance - Food Safety segment revenues were $152.1 million, a decrease of 4.6%, with growth in pathogen detection products [6] - Animal Safety segment sales were $57.1 million, a slight decrease of 0.8%, driven by higher sales in biologics and wound care [6] - Genomics segment returned to positive core revenue growth in the mid-single-digit range, despite a decline in the companion animal market [6]

Financing & Review - In September 2025, the Beijing Stock Exchange (BSE) issued 4 new stocks, raising a total of CNY 1.089 billion; from January to September 2025, a total of 16 new stocks were issued, raising CNY 5.027 billion[5] - As of the end of September, there are 9 companies that have passed the review but not yet registered, with a proposed fundraising of CNY 2.588 billion; 6 companies have been registered but not yet issued, with a proposed fundraising of CNY 1.210 billion[5] Subscription & Issuance - The median first-day increase for the 3 new stocks listed in September was +304.65%, with individual increases of +736.78%, +304.65%, and +120.34% for Sanxie Electric, Shichang Co., and Jinhua New Materials respectively[3] - The theoretical subscription yield for the new stocks Sanxie Electric, Shichang Co., and Jinhua New Materials was +0.165%, +0.076%, and +0.080% respectively[3] Market Trends & Predictions - The cumulative yield for new stock subscriptions in 2024 is +4.01% (23 new stocks issued), while the cumulative theoretical yield for new stock subscriptions from January to September 2025 is +1.75% (14 new stocks issued)[3] - The average top subscription amount in September 2025 was CNY 12.93 million, with a median capital freeze range of CNY 649.59 billion to CNY 851.19 billion[5] Investment Analysis - The BSE is expected to maintain a regular issuance pace, with 7 companies registered and 4 approved in September; the outlook suggests a weekly issuance rhythm is likely to continue[6] - There are currently 15 companies that have passed the review and are awaiting issuance, indicating a rich pipeline of quality projects[6] Risk Factors - Potential risks include slower-than-expected issuance speed, lower-than-expected stock price increases, macroeconomic downturns, and rapid growth in new stock subscription accounts[6]

Group 1 - The company reported a revenue of 148 million yuan for the first half of 2025, a year-on-year decrease of 33.43% [1] - The net profit attributable to shareholders was -60.41 million yuan, compared to -49.14 million yuan in the same period last year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -61.24 million yuan, compared to -50.90 million yuan in the previous year [1] Group 2 - The company generated a net cash flow from operating activities of 12.12 million yuan, an improvement from -86.10 million yuan in the same period last year [1] - The projected net profits for 2023 and 2024 are -51.70 million yuan and -158 million yuan, respectively [1] - The company raised a total of 912.15 million yuan from its initial public offering, with a net amount of 808.82 million yuan, exceeding the original plan by 40.83 million yuan [2] Group 3 - The funds raised are intended for the construction of testing bases in Xi'an and Chengdu, the establishment of a research and development center, and to supplement working capital [2] - The total issuance costs for the initial public offering amounted to 103.34 million yuan, including underwriting and sponsorship fees of 72.97 million yuan [2]

Core Viewpoint - The article establishes an analytical method using high-performance liquid chromatography (HPLC) to determine six phenolic substances in Conghua olives, optimizing various conditions for effective separation and detection [2][4][40]. Methodology - The method involves weighing 0.5g of dried Conghua olive powder, dissolving it in isopropyl alcohol, and subjecting it to ultrasonic extraction for 30 minutes, followed by solid-phase extraction and filtration before HPLC analysis [4][6]. - The Eclipse XDB-C18 chromatographic column was selected for separation, and a diode array detector was used to optimize the testing conditions [4][12]. Results - The study found that the peak areas of gallic acid, hydroxytyrosol, oleuropein, and elenolic acid showed good linear relationships within specified concentration ranges, with R² values greater than 0.995 [4][5]. - Detection limits for the six substances were established, with gallic acid at 2.09 mg/kg and hydroxytyrosol at 2.20 mg/kg, among others [5][33]. Recovery and Precision - The recovery rates for the substances ranged from 84% to 116%, with relative standard deviations between 0.014% and 0.15%, indicating the method's reliability [5][34]. Conclusion - The optimized method provides a reliable approach for determining the content of six phenolic substances in Conghua olives, contributing valuable insights for researchers in the field [40].

Core Viewpoint - The article highlights high-paying job opportunities in the detection and technical support sectors during the National Day holiday, encouraging job seekers to update their resumes and explore these positions. Group 1: Job Opportunities - Shanghai Kailai is hiring a Laboratory Supervisor with a salary range of 8k-10k, requiring a bachelor's degree in relevant fields and over 5 years of experience [2] - European Continental is looking for a Testing Engineer in Hangzhou with a salary range of 5k-7k, requiring at least one year of relevant testing experience [3] - Hunan Lingfeng is seeking a Laboratory Technician in Changsha with a salary range of 4k-6k, requiring a bachelor's degree in related fields [4] Group 2: Specific Job Requirements - Flash Spectrum is hiring a Life Science Instrument Technical Engineer in Hangzhou with a salary range of 10k-20k, requiring a master's degree in life sciences and over one year of relevant experience [6][7] - Shanghai Kezhe is looking for a Life Science Instrument Technical Support Engineer in Nanjing, salary negotiable, requiring a master's degree and familiarity with liquid chromatography [8][9] - Beistech is seeking an Analytical Testing Engineer in Beijing, salary negotiable, responsible for various technical services related to analytical testing [10] Group 3: Additional Positions - China Grain Engineering is hiring for Microbial Testing in Wuhan, salary negotiable, requiring knowledge of food safety standards and microbial testing methods [14][15] - Mingjie Bio is looking for a Drug Analysis Assistant in Shanghai, salary negotiable, requiring a degree in pharmacy or chemistry and experience in drug analysis [16] - Huace Testing is seeking an Environmental Testing Technician in Shenzhen, salary negotiable, requiring a degree in environmental science or related fields [17][18]

Core Viewpoint - The company announced a change in the use of part of the raised funds, reallocating 50 million yuan from the original project to a new project, which is expected to enhance the efficiency of fund utilization [1] Fund Allocation Changes - The company plans to change the use of 50 million yuan of the raised funds, which represents 3.37% of the net amount raised [1] - The funds were originally intended for the "East China Testing Base Project" and will now be redirected to the "Central China (Wuhan) Testing Base Project" [1] - This change does not involve any new investment projects and does not constitute a related party transaction [1] Governance - The proposal for changing the fund usage will be submitted for approval at the upcoming shareholders' meeting [1]

Core Viewpoint - Guangdian Measurement's stock price has shown fluctuations with a year-to-date increase of 18.83%, indicating a mixed performance in recent trading periods [1][2]. Company Overview - Guangdian Measurement Testing Group Co., Ltd. was established on May 24, 2002, and listed on November 8, 2019. The company is located in Panyu District, Guangzhou, and specializes in measurement services, testing services, and the development of testing equipment [1]. - The main business revenue composition includes: reliability and environmental testing (25.28%), measurement services (23.54%), life sciences (14.24%), electromagnetic compatibility testing (11.22%), and others [1]. Financial Performance - For the first half of 2025, Guangdian Measurement achieved operating revenue of 1.478 billion yuan, a year-on-year increase of 10.01%. The net profit attributable to shareholders was 97.316 million yuan, reflecting a year-on-year growth of 22.11% [2]. - Since its A-share listing, the company has distributed a total of 607 million yuan in dividends, with 481 million yuan distributed in the last three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Guangdian Measurement was 29,400, a decrease of 13.47% from the previous period. The average circulating shares per person increased by 13.16% to 18,011 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 13.319 million shares, a decrease of 1.5401 million shares from the previous period. New entrants among the top shareholders include Xinyi Xirui Two-Year Holding Period Mixed A and Huisheng Huize Mixed A [3].

Group 1 - The company, Electric Power Research Institute (300215.SZ), specializes in high and low voltage electrical equipment testing services, with high voltage testing services accounting for 70% to 80% of its business [1] - The company has been deeply engaged in the testing industry for many years, establishing itself as a benchmark in testing standards and capabilities [1] - For detailed operational information, the company advises stakeholders to refer to its regular reports, specifically the "Management Discussion and Analysis" section [1]

Market Overview - The professional services sector experienced a decline of 1.19% on September 26, with Shijiazhuang Testing leading the drop [1] - The Shanghai Composite Index closed at 3828.11, down 0.65%, while the Shenzhen Component Index closed at 13209.0, down 1.76% [1] Individual Stock Performance - Notable gainers in the professional services sector included: - Wai Fu Holdings (600662) with a closing price of 5.36, up 1.52% on a trading volume of 110,800 shares, totaling 59.17 million yuan [1] - Jian Yan Institute (603183) closed at 4.31, up 0.94% with a trading volume of 109,800 shares, totaling 47.58 million yuan [1] - Significant decliners included: - Shicun Testing (301228) which fell 4.06% to 30.25 with a trading volume of 37,600 shares, totaling 116 million yuan [2] - Keri International (300662) also dropped 4.06% to 29.56 with a trading volume of 49,300 shares, totaling 148 million yuan [2] Capital Flow Analysis - The professional services sector saw a net outflow of 164 million yuan from institutional investors, while retail investors experienced a net inflow of 129 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors showed interest [2][3] Detailed Capital Flow by Stock - Notable stocks with significant capital flow include: - Guangdian Measurement (002967) with a net inflow of 11.10 million yuan from institutional investors, but a net outflow of 18.33 million yuan from retail investors [3] - Xince Standard (300938) had a net inflow of 10.45 million yuan from institutional investors, while retail investors saw a net outflow of 18.12 million yuan [3]